Sovereign Financial Group, Inc. Ovid Therapeutics Inc. Transaction History
Sovereign Financial Group, Inc.
- $514 Million
- Q3 2025
A detailed history of Sovereign Financial Group, Inc. transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Sovereign Financial Group, Inc. holds 10,000 shares of OVID stock, worth $14,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$14,000% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OVID
# of Institutions
71Shares Held
33MCall Options Held
15.6KPut Options Held
0-
Black Rock Inc. New York, NY3.99MShares$5.59 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$5.4 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.64MShares$3.69 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY2.23MShares$3.12 Million0.35% of portfolio
-
Acadian Asset Management LLC Boston, MA2.11MShares$2.95 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $98.6M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...